To the full analysis
Edenred stock: growth
EDEN.PAEdenred reported $3.03B in revenue for fiscal 2025, down 4.3% on the prior year, up 13.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−5.8%
per year from 2007 to 2025, per share −6.1%
Earnings (Annual rate)
−2.9%
per year from 2007 to 2025, per share −3.2%
Free cash flow (Annual rate)
−2.5%
per year from 2007 to 2025, per share −2.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2007 | |
|---|---|---|---|
| Revenue | 13.9% | 10.6% | −5.8% |
| Revenue per share | 14.5% | 10.1% | −6.1% |
| Earnings | 17.0% | 11.4% | −2.9% |
| Earnings per share | 17.6% | 10.8% | −3.2% |
| Free cash flow | −8.2% | 13.1% | −2.5% |
| Free cash flow per share | −7.8% | 12.6% | −2.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $8.89B | $978.45M | $1.57B |
| 2008 | $8.43B | $637.16M | $1.16B |
| 2009 | $7.72B | −$293.65M | $378.97M |
| 2010 | $1.07B | $107.49M | $284.78M |
| 2011 | $1.14B | $214.97M | $277.03M |
| 2012 | $1.18B | $202.78M | $259.3M |
| 2013 | $1.05B | $177.3M | $206.11M |
| 2014 | $1.06B | $181.73M | $335.75M |
| 2015 | $1.11B | $196.13M | $290.32M |
| 2016 | $1.19B | $199.46M | $393.38M |
| 2017 | $1.39B | $267.05M | $460.97M |
| 2018 | $1.47B | $281.46M | $483.13M |
| 2019 | $1.74B | $345.73M | $838.83M |
| 2020 | $1.58B | $263.73M | $1.53B |
| 2021 | $1.75B | $346.84M | $298.08M |
| 2022 | $2.15B | $427.73M | $650.45M |
| 2023 | $2.56B | $295.86M | $955.18M |
| 2024 | $3.16B | $561.81M | $899.78M |
| 2025 | $3.03B | $577.32M | $998.4M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong since 11 Nov 2026, previously Neutral
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.